oxcarbazepine

Generic: oxcarbazepine

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oxcarbazepine
Generic Name oxcarbazepine
Labeler camber pharmaceuticals, inc.
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

oxcarbazepine 60 mg/mL

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-687
Product ID 31722-687_2dd9d0f0-2c98-d0dd-e063-6294a90a7c1b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216749
Listing Expiration 2026-12-31
Marketing Start 2023-10-20

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722687
Hyphenated Format 31722-687

Supplemental Identifiers

RxCUI
283536
UPC
0331722687256
UNII
VZI5B1W380
NUI
N0000175753 N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxcarbazepine (source: ndc)
Generic Name oxcarbazepine (source: ndc)
Application Number ANDA216749 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (31722-687-25) / 250 mL in 1 BOTTLE
source: ndc

Packages (1)

31722-687-25 1 BOTTLE in 1 CARTON (31722-687-25) / 250 mL in 1 BOTTLE

Ingredients (1)

oxcarbazepine (60 mg/mL)

Linked Drug Pages (1)

OXCARBAZEPINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2dd9d0f0-2c98-d0dd-e063-6294a90a7c1b", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0331722687256"], "unii": ["VZI5B1W380"], "rxcui": ["283536"], "spl_set_id": ["a18f591b-587e-4769-8ac2-9cfba0b82526"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (31722-687-25)  / 250 mL in 1 BOTTLE", "package_ndc": "31722-687-25", "marketing_start_date": "20231020"}], "brand_name": "OXCARBAZEPINE", "product_id": "31722-687_2dd9d0f0-2c98-d0dd-e063-6294a90a7c1b", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "31722-687", "generic_name": "OXCARBAZEPINE", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "60 mg/mL"}], "application_number": "ANDA216749", "marketing_category": "ANDA", "marketing_start_date": "20231020", "listing_expiration_date": "20261231"}